Alzheimers Parkinsons ALS

386 bookmarks
Newest
Dramatic Recovery In Parkinson’s Patient with Gluten Free Diet
Dramatic Recovery In Parkinson’s Patient with Gluten Free Diet
Could gluten's toxicity extend to the nervous system, producing symptoms identical to classical Parkinson's disease? A compelling case study adds to a growing body of research indicating that wheat's neurotoxicity is greatly underestimated.
·greenmedinfo.com·
Dramatic Recovery In Parkinson’s Patient with Gluten Free Diet
Benefits of Vitamins in the Treatment of Parkinson’s Disease
Benefits of Vitamins in the Treatment of Parkinson’s Disease
Parkinson’s disease (PD) is the second most common neurodegenerative disease in the elderly, which is clinically characterized by bradykinesia, resting tremor, abnormal posture balance, and hypermyotonia. Currently, the pathogenic mechanism of PD remains unclear. Numerous clinical studies as well as animal and cell experiments have found a certain relationship between the vitamin family and PD. The antioxidant properties of vitamins and their biological functions of regulating gene expression may be beneficial for the treatment of PD. Current clinical evidence indicates that proper supplementation of various vitamins can reduce the incidence of PD in the general population and improve the clinical symptoms of patients with PD; nevertheless, the safety of regular vitamin supplements still needs to be highlighted. Vitamin supplementation may be an effective adjuvant treatment for PD. In this review, we summarized the biological correlations between vitamins and PD as well as the underlying pathophysiological mechanisms. Additionally, we elaborated the therapeutic potentials of vitamins for PD.
·hindawi.com·
Benefits of Vitamins in the Treatment of Parkinson’s Disease
Beneficial effects of trehalose on striatal dopaminergic deficits in rodent and primate models of synucleinopathy in Parkinson's disease. - PubMed - NCBI
Beneficial effects of trehalose on striatal dopaminergic deficits in rodent and primate models of synucleinopathy in Parkinson's disease. - PubMed - NCBI
Disease modification in Parkinson's disease (PD) is an unmet medical need. In the current study, we evaluated trehalose, a safe and well-tolerated disaccharide that has previously demonstrated efficacy in rodent models of neurodegenerative diseases, including PD. In a rat model of PD, based on deliv …
·ncbi.nlm.nih.gov·
Beneficial effects of trehalose on striatal dopaminergic deficits in rodent and primate models of synucleinopathy in Parkinson's disease. - PubMed - NCBI
Glucosamine and Its Analogues as Modulators of Amyloid-ß Toxicity ACS Medicinal Chemistry Letters
Glucosamine and Its Analogues as Modulators of Amyloid-ß Toxicity ACS Medicinal Chemistry Letters
In Alzheimer’s disease (AD), amyloid-β (Aβ) oligomers are considered key mediators of synaptic dysfunction and cognitive impairment. These unstable intermediate Aβ species can interfere with different cellular organelles, leading to neuronal cell death, through the formation of Ca2+-permeable membrane pores, impairment in the levels of acetylcholine neurotransmitters, increased insulin resistance, promotion of pro-inflammatory cascades, among others. Based on a series of evidences that indicate the key role of glycosaminoglycans (GAGs) in amyloid plaque formation, we evaluated the capacity of four monosaccharides, i.e., glucosamine (GlcN), N-acetyl glucosamine (GlcNAc), glucosamine-6-sulfate (GlcN6S), and glucosamine-6-phosphate (GlcN6P), to reduce the Aβ-mediated pathological hallmarks. The tested monosaccharides, in particular, GlcN6S and GlcN6P, were able to interact with Aβ aggregates, reducing neuronal cell death, Aβ-mediated damage to the cellular membrane, acetylcholinesterase activity, insulin resistance, and pro-inflammation levels.
·pubs.acs.org·
Glucosamine and Its Analogues as Modulators of Amyloid-ß Toxicity ACS Medicinal Chemistry Letters
Fucoidan serves a neuroprotective effect in an Alzheimer’s disease model
Fucoidan serves a neuroprotective effect in an Alzheimer’s disease model
This is a journal and virtual library useful to scientists, physicians and patients. The site contains medical and biology information as articles, databases, books, lectures and more. The site also contains the forms to search the most useful sites on the Web.
·bioscience.org·
Fucoidan serves a neuroprotective effect in an Alzheimer’s disease model
Macrophage Migration Inhibitory Factor is subjected to glucose modific (...)
Macrophage Migration Inhibitory Factor is subjected to glucose modific (...)
Glucose and glucose metabolites are able to adversely modify proteins through a non-enzymatic reaction called glycation, which is associated with the pathology of Alzheimer’s Disease (AD) and is a characteristic of the hyperglycaemia induced by diabetes. However, the precise protein glycation profile that characterises AD is poorly defined and the molecular link between hyperglycaemia and AD is unknown. In this study, we define an early glycation profile of human brain using fluorescent phenylboronate gel electrophoresis and identify early glycation and oxidation of macrophage migration inhibitory factor (MIF) in AD brain. This modification inhibits MIF enzyme activity and ability to stimulate glial cells. MIF is involved in immune response and insulin regulation, hyperglycaemia, oxidative stress and glycation are all implicated in AD. Our study indicates that glucose modified and oxidised MIF could be a molecular link between hyperglycaemia and the dysregulation of the innate immune system in AD.
·nature.com·
Macrophage Migration Inhibitory Factor is subjected to glucose modific (...)
Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease. - PubMed - NCBI
Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease. - PubMed - NCBI
Alzheimer's disease is a neurodegenerative disorder involving extracellular plaques (amyloid-β) and intracellular tangles of tau protein. Recently, tangle formation has been identified as a major event involved in the neurodegenerative process, due to the conversion of either soluble peptides or oli …
·ncbi.nlm.nih.gov·
Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease. - PubMed - NCBI
How to Stop Dementia and Alzheimer's Naturally - YouTube
How to Stop Dementia and Alzheimer's Naturally - YouTube
Dementia and Alzheimer's a big problem in industrialized countries. With the aging population at greater and greater risk for these conditions, it is imperative to understand that there are a variety of natural ways to stop dementia in its tracks. In this video, Dr. Osborne breaks down 6 natural ways you can overcome brain inflammation (brainflammation) including: 1. Avoid gluten 2. Eat lots of healthy fats 3. Avoid eating excessive carbohydrates 4. Take exercise more seriously 5. Maintain a healthy blood sugar 6. Do a medication review with your doctor. Remember, natural help is all about your diet and your lifestyle. There are no magic cures. You have to put in the work. To connect with Dr. Osborne visit: Facebook: https://www.facebook.com/DoctorPeterO... Pinterest: https://www.pinterest.com/docosborne/ Instagram: https://www.instagram.com/drosborne Twitter: https://twitter.com/glutenology *These statements have not been evaluated by the Food and Drug Administration. This video is not intended to diagnose, treat, cure or prevent any disease. It is strictly intended for educational purposes only. Additionally, this information is not intended to replace the advice of your physician. Dr. Osborne is not a medical doctor. He does not treat or diagnose disease. He offers nutritional support to people seeking an alternative from traditional medicine. Dr. Osborne is licensed with the Pastoral Medical Association.
·youtube.com·
How to Stop Dementia and Alzheimer's Naturally - YouTube
Human amyloid-beta acts as natural antibiotic in the brain Alzheimer's (...)
Human amyloid-beta acts as natural antibiotic in the brain Alzheimer's (...)
A new study provides additional evidence that amyloid-beta protein -- which is deposited in the form of beta-amyloid plaques in the brains of patients with Alzheimer's disease -- is a normal part of the innate immune system, the body's first-line defense against infection.
·sciencedaily.com·
Human amyloid-beta acts as natural antibiotic in the brain Alzheimer's (...)